Oral obeldesivir, an anti-viral drug, prevents Marburg disease in non-human primates according to research conducted at the University of Texas Medical Branch’s Galveston National Laboratory, in collaboration with Gilead Sciences and the National Institute of Allergy and Infectious Diseases.